Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Depression 4 Head and Neck Neoplasms 3 Breast Neoplasms 3 Triple Negative Breast Neoplasms 2 Fatigue 2 Anxiety Disorders 2 Uterine Cervical Neoplasms 1 Urogenital Neoplasms 1 Urinary Bladder Neoplasms 1 Sleep Wake Disorders 1 Recurrence 1 Radiation Fibrosis Syndrome 1 Prostatic Neoplasms 1 Prostatic Hyperplasia 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Patient Acceptance of Health Care 1 Pain 1 Neoplasm Metastasis 1 Myasthenia Gravis 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Calculi 1 Inflammatory Breast Neoplasms 1 Immune Checkpoint Inhibitor-Induced Dermatitis 1 Health Education 1 Constriction, Pathologic 1

Interventions

Nivolumab 6 Specimen Handling 5 Magnetic Resonance Spectroscopy 4 Ipilimumab 4 HhAntag691 4 CTLA-4 Antigen 3 Biopsy 3 prednylidene 2 deltacortene 2 Standard of Care 2 Prednisone 2 talimogene laherparepvec 1 sonidegib 1 relatlimab 1 daromun 1 cemiplimab 1 X-Rays 1 Watchful Waiting 1 Vitamin D 1 Therapeutics 1 Tacrolimus 1 Sunscreening Agents 1 Sirolimus 1 Radiotherapy 1 Practice Guidelines as Topic 1 Photochemotherapy 1 Observation 1 Niacinamide 1 Mohs Surgery 1 MAPRE1 protein, human 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Basal Cell × Therapeutics × 90 days × Clear all

NCT03610022 2026-05-19

OPTIVISMO-1

University Hospital, Bordeaux

Phase 4 Completed

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡